[
  {
    "ts": null,
    "headline": "Pfizer : Investor Communication",
    "summary": "Supplemental Proxy Material April 7, 2025 Pfizer 2025 Executive Summary - Key Ballot...",
    "url": "https://finnhub.io/api/news?id=45aef257c54baa0256aee035064fa10f6fcb8739bb77935ae4c42979d938a6b8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744325885,
      "headline": "Pfizer : Investor Communication",
      "id": 133875444,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Supplemental Proxy Material April 7, 2025 Pfizer 2025 Executive Summary - Key Ballot...",
      "url": "https://finnhub.io/api/news?id=45aef257c54baa0256aee035064fa10f6fcb8739bb77935ae4c42979d938a6b8"
    }
  },
  {
    "ts": null,
    "headline": "Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know",
    "summary": "A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.",
    "url": "https://finnhub.io/api/news?id=14e2d92735678ed9f65cc919a36522904cc36e69b65166bec7810166ca787618",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744305064,
      "headline": "Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know",
      "id": 133873303,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.",
      "url": "https://finnhub.io/api/news?id=14e2d92735678ed9f65cc919a36522904cc36e69b65166bec7810166ca787618"
    }
  },
  {
    "ts": null,
    "headline": "Vaxcyte Stock Plummets 56% in a Month: Here's the Reason",
    "summary": "The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.",
    "url": "https://finnhub.io/api/news?id=98c9b948bca3ab811e580c52fd7c58bfb2f5197343a2bd625a6ebc131e74d119",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744304820,
      "headline": "Vaxcyte Stock Plummets 56% in a Month: Here's the Reason",
      "id": 133873358,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.",
      "url": "https://finnhub.io/api/news?id=98c9b948bca3ab811e580c52fd7c58bfb2f5197343a2bd625a6ebc131e74d119"
    }
  },
  {
    "ts": null,
    "headline": "S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash",
    "summary": "Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.",
    "url": "https://finnhub.io/api/news?id=2c962a5d6369911f20d54803752bd0307ef39e280a10344546d37968e73cb860",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744304303,
      "headline": "S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash",
      "id": 133873314,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.",
      "url": "https://finnhub.io/api/news?id=2c962a5d6369911f20d54803752bd0307ef39e280a10344546d37968e73cb860"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d98d251c0afb5372818a3ae107c905096fd48b4992e63a7e727c848f166861ef",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744302960,
      "headline": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
      "id": 133888295,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d98d251c0afb5372818a3ae107c905096fd48b4992e63a7e727c848f166861ef"
    }
  },
  {
    "ts": null,
    "headline": "Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.",
    "summary": "Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might \"go wild\" on biotech stocks.",
    "url": "https://finnhub.io/api/news?id=ebe2fe3863e452ce1f401d2c50f1387550a453d0542dbec5a3f279f530e924c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744300912,
      "headline": "Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.",
      "id": 133853253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might \"go wild\" on biotech stocks.",
      "url": "https://finnhub.io/api/news?id=ebe2fe3863e452ce1f401d2c50f1387550a453d0542dbec5a3f279f530e924c4"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24",
    "summary": "NEW YORK, April 10, 2025--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual 2025 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 24, 2025. Pfizer has designed the virtual Annual Meeting to ensure that its shareholders who participate will be afforded comparable rights and opportunities to participate as they would at an in-person meeting.",
    "url": "https://finnhub.io/api/news?id=b3f8f7852b9423813e4e5ef40ca1f6a3e834acb967ed9117d49ef140d685ffee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744297200,
      "headline": "Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24",
      "id": 133853361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NEW YORK, April 10, 2025--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual 2025 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 24, 2025. Pfizer has designed the virtual Annual Meeting to ensure that its shareholders who participate will be afforded comparable rights and opportunities to participate as they would at an in-person meeting.",
      "url": "https://finnhub.io/api/news?id=b3f8f7852b9423813e4e5ef40ca1f6a3e834acb967ed9117d49ef140d685ffee"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?",
    "summary": "PFE stock is likely to be a great pick for value investors, considering its cheap valuation, as well as for income investors due to its sky-high dividend yield.",
    "url": "https://finnhub.io/api/news?id=e1eff9791214e0f89b3e7516e5cd7b207e8a1340d0fbd408116bc7ca58c8e4eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744292640,
      "headline": "Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?",
      "id": 133853363,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PFE stock is likely to be a great pick for value investors, considering its cheap valuation, as well as for income investors due to its sky-high dividend yield.",
      "url": "https://finnhub.io/api/news?id=e1eff9791214e0f89b3e7516e5cd7b207e8a1340d0fbd408116bc7ca58c8e4eb"
    }
  },
  {
    "ts": null,
    "headline": "Next-generation Covid-19 vaccines currently being tested",
    "summary": "Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, Ocugen, and Pfizer.",
    "url": "https://finnhub.io/api/news?id=e619d02defbb67bb597350ddb6402a1d7711056e8ed682574efee4af8a1be939",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744281050,
      "headline": "Next-generation Covid-19 vaccines currently being tested",
      "id": 133844423,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, Ocugen, and Pfizer.",
      "url": "https://finnhub.io/api/news?id=e619d02defbb67bb597350ddb6402a1d7711056e8ed682574efee4af8a1be939"
    }
  },
  {
    "ts": null,
    "headline": "Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline",
    "summary": "Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline",
    "url": "https://finnhub.io/api/news?id=36133ccf9d744694bed9ba6033ab5607bd8a1aa4e4df9c366c8061ebe0df812b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744278858,
      "headline": "Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline",
      "id": 133843578,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=36133ccf9d744694bed9ba6033ab5607bd8a1aa4e4df9c366c8061ebe0df812b"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights General Motors, JD.com, Pfizer, StoneCo and Enersys",
    "summary": "General Motors, JD.com, Pfizer, StoneCo and Enersys have been highlighted in this Screen of The Week article.",
    "url": "https://finnhub.io/api/news?id=d53ca3ea6282569d0bca520da22b15d6db5fe19fc5087f84023ec438f1302d51",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744275600,
      "headline": "Zacks.com featured highlights General Motors, JD.com, Pfizer, StoneCo and Enersys",
      "id": 133844424,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "General Motors, JD.com, Pfizer, StoneCo and Enersys have been highlighted in this Screen of The Week article.",
      "url": "https://finnhub.io/api/news?id=d53ca3ea6282569d0bca520da22b15d6db5fe19fc5087f84023ec438f1302d51"
    }
  }
]